VYNT - Vyant Bio GAAP EPS of -$0.32 misses by $0.16 revenue of $0.3M in-line May, 16 2022 09:04 AM Vyant Bio Inc. Vyant Bio press release (NASDAQ:VYNT): Q1 GAAP EPS of -$0.32 misses by $0.16. Revenue of $0.3M (+200.0% Y/Y) in-line. Shares +1.72% PM. For further details see: Vyant Bio GAAP EPS of -$0.32 misses by $0.16, revenue of $0.3M in-line